Open AccessA Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications
Author(s) -
Oscar C. Marroquin,
Faith Selzer,
Suresh Mulukutla,
David O. Williams,
Helen Vlachos,
Robert L. Wilensky,
JeanFrançois Tanguay,
Elizabeth M. Holper,
J. Dawn Abbott,
Joon S. Lee,
Conrad Smith,
William Anderson,
Sheryl F. Kelsey,
Kevin E. Kip
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0706258
Subject(s) - medicine , bare metal , drug , off label use , pharmacology , stent , restenosis
Recent reports suggest that off-label use of drug-eluting stents is associated with an increased incidence of adverse events. Whether the use of bare-metal stents would yield different results is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom